Medicare isn't a game changer
Digest more
CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through the end of 2027.
A new Medicare program launching on Wednesday will enable millions more Americans, particularly those aged 65 and older, to access obesity medications for only $50 a month. This 18-month trial will offer drugs from Novo Nordisk and Eli Lilly,
Woman's World on MSN
Medicare's new $50 GLP-1 bridge program starts July 1: Do you qualify?
The new Medicare GLP-1 Bridge program, which will allow seniors to get certain GLP-1 drugs for just $50 a month and is part of The Better Approaches to Lifestyle and Nutrition for Comprehensive Health (BALANCE) Program,
Medicare’s new GLP-1 Bridge program boosts seniors’ access to weight-loss drugs through 2027—see top GLP-1 and biotech stocks to watch now.
The State of Indiana today announced a groundbreaking partnership with the Centers for Medicare & Medicaid Services (CMS) and Oracle to pilot
The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than what U.S. consumers pay for the same products. At issue is the ...
This article provides an update on progress since last year and lays out new work in 2024 in three areas: safety-net provider participation in models to improve care for more beneficiaries; data collection that supports whole-person care; and payment ...
The Trump administration told states last week it will exercise more stringent financial oversight of waivers that states use to design pilot programs under Medicaid, the state-federal program for
